Precision Medicine, Retail Growth, AI in Healthcare: Health Week

Mexico strengthens its healthcare ecosystem with the Tecnológico de Monterrey’s new Genomic and Clinical Innovation Unit, advancing precision medicine, while IMSS expands blood donation drives nationwide to support timely transfusions. The retail pharmacy market is set to reach US$11.6 billion by 2028, reflecting sustained sector growth. Meanwhile, AI is helping healthcare professionals dedicate more time to patient interaction, and Mexico is gaining global prominence in the generics and novel drug market.

This is The Week in Health! 

Tecnológico de Monterrey Opens Precision Medicine Unit

Tecnológico de Monterrey and the Translational Institute of Genomic Singularity (ITRASIG) inaugurated the Genomic and Clinical Innovation Unit in Mexico City, aiming to advance public health diagnostics. The facility will focus on precision medicine and high-throughput genetic analysis.

IMSS Expands Blood Donation Drives Across Mexico

The Mexican Social Security Institute (IMSS) has increased its offsite blood donation campaigns to ensure timely and safe transfusions for millions nationwide. These initiatives target universities, workplaces, and public and private institutions.

Mexico’s Retail Pharmacy Market to Reach US$11.6 Billion by 2028

Mexico’s retail pharmacy sector is projected to grow at an annual average rate of 6.5% over the next three years, with total sales expected to rise from US$9.6 billion (MX$176 billion) in 2025 to US$11.6 billion in 2028, according to a study by RX México and Euromonitor.

AI Supports the Humanization of HealthCare: Globant 

Technology should enable healthcare professionals to spend more time interacting with those they serve, says Globant’s Juan Martín Santos.

The Generic Revolution: Mexico's Ascendance in Global Medicine

As the global pharma market shifts due to the expansion of generics, Mexico is emerging as a leader in novel drug registration, writes McCann Health SI’s Héctor Salinas.